The 2006 discovery that mature skin cells can be converted into stem cells opened up exciting possibilities in regenerative medicine. Now almost a decade later, the Nobel-Prize winning research of Shinya Yamanaka is still opening doors for scientists across different arms of medical research. In what it labels as a first, a team from the University of North Carolina at Chapel Hill (UNC) has built on this technology to transform adult skin cells into cancer-killing stem cells that seek and destroy brain tumors.
Glioblastomas are the most common and fatal form of brain cancer, carrying a survival rate beyond two years of just 30 percent. While surgeons can remove the tumor, often its cancerous tentacles take root deep in the brain and allow it to grow back. Most patients die within a year and a half of diagnosis.
Radiation and chemotherapy can […]